Skip to main content

Lymphadenopathy clinical trials at UCSF
1 in progress, 1 open to new patients

  • Retroperitoneal Lymph Node Dissection in Treating Patients With Stage I-IIA Testicular Seminoma

    open to eligible males ages 16 years and up

    This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroperitoneum is the space in the body behind the intestines that is typically the first place that seminoma spreads. RPLND is a surgery that removes lymph nodes in this area to treat testicular seminoma and may experience fewer long-term toxicities, such as a second cancer, cardiovascular disease, metabolic syndrome (pre-diabetes), or lung disease.

    San Francisco, California and other locations